The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Urine Based Glucose Monitoring-Global Market Insights and Sales Trends 2025
Synopsis
Urine-based glucose monitoring is a method used to measure glucose levels in urine samples. While not as accurate as blood-based monitoring, urine testing can provide an indication of glucose levels and help in diabetes management.
The global Urine Based Glucose Monitoring market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Urine Based Glucose Monitoring in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Urine Based Glucose Monitoring market. Wearable Blood Glucose Monitoring Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Table Top Blood Glucose Monitoring Systems segment is estimated at % CAGR for the next seven-year period.
The market for urine-based glucose monitoring is driven by factors such as its simplicity and cost-effectiveness, making it a viable option in certain healthcare settings or resource-limited environments. However, the growing popularity of blood-based and non-invasive glucose monitoring methods may impact the market's growth in the long term.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Urine Based Glucose Monitoring, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Urine Based Glucose Monitoring market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Urine Based Glucose Monitoring market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Urine Based Glucose Monitoring sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Urine Based Glucose Monitoring covered in this report include Abbott, Medtronic, Roche, Bayer AG, B. Braun, Nipro Diagnostics, Life Scan Inc.(J&J), Arkray Devices and Nova Biomedical, etc.
The global Urine Based Glucose Monitoring market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Global Urine Based Glucose Monitoring market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Urine Based Glucose Monitoring market, Segment by Type:
Wearable Blood Glucose Monitoring Systems
Table Top Blood Glucose Monitoring Systems
Global Urine Based Glucose Monitoring market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Urine Based Glucose Monitoring manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Urine Based Glucose Monitoring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Urine-based glucose monitoring is a method used to measure glucose levels in urine samples. While not as accurate as blood-based monitoring, urine testing can provide an indication of glucose levels and help in diabetes management.
The global Urine Based Glucose Monitoring market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Urine Based Glucose Monitoring in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Urine Based Glucose Monitoring market. Wearable Blood Glucose Monitoring Systems, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Table Top Blood Glucose Monitoring Systems segment is estimated at % CAGR for the next seven-year period.
The market for urine-based glucose monitoring is driven by factors such as its simplicity and cost-effectiveness, making it a viable option in certain healthcare settings or resource-limited environments. However, the growing popularity of blood-based and non-invasive glucose monitoring methods may impact the market's growth in the long term.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Urine Based Glucose Monitoring, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Urine Based Glucose Monitoring market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Urine Based Glucose Monitoring market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Urine Based Glucose Monitoring sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Urine Based Glucose Monitoring covered in this report include Abbott, Medtronic, Roche, Bayer AG, B. Braun, Nipro Diagnostics, Life Scan Inc.(J&J), Arkray Devices and Nova Biomedical, etc.
The global Urine Based Glucose Monitoring market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Global Urine Based Glucose Monitoring market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Urine Based Glucose Monitoring market, Segment by Type:
Wearable Blood Glucose Monitoring Systems
Table Top Blood Glucose Monitoring Systems
Global Urine Based Glucose Monitoring market, by Application
Hospitals
Clinics
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Urine Based Glucose Monitoring manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Urine Based Glucose Monitoring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Urine Based Glucose Monitoring Market Overview
1.1 Urine Based Glucose Monitoring Product Overview
1.2 Urine Based Glucose Monitoring Market Segment by Type
1.2.1 Wearable Blood Glucose Monitoring Systems
1.2.2 Table Top Blood Glucose Monitoring Systems
1.3 Global Urine Based Glucose Monitoring Market Size by Type
1.3.1 Global Urine Based Glucose Monitoring Market Size Overview by Type (2018-2029)
1.3.2 Global Urine Based Glucose Monitoring Historic Market Size Review by Type (2018-2023)
1.3.3 Global Urine Based Glucose Monitoring Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Urine Based Glucose Monitoring Sales Breakdown by Type (2018-2023)
1.4.2 Europe Urine Based Glucose Monitoring Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Urine Based Glucose Monitoring Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Urine Based Glucose Monitoring Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Urine Based Glucose Monitoring Sales Breakdown by Type (2018-2023)
2 Global Urine Based Glucose Monitoring Market Competition by Company
2.1 Global Top Players by Urine Based Glucose Monitoring Sales (2018-2023)
2.2 Global Top Players by Urine Based Glucose Monitoring Revenue (2018-2023)
2.3 Global Top Players by Urine Based Glucose Monitoring Price (2018-2023)
2.4 Global Top Manufacturers Urine Based Glucose Monitoring Manufacturing Base Distribution, Sales Area, Product Type
2.5 Urine Based Glucose Monitoring Market Competitive Situation and Trends
2.5.1 Urine Based Glucose Monitoring Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Urine Based Glucose Monitoring Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Urine Based Glucose Monitoring as of 2022)
2.7 Date of Key Manufacturers Enter into Urine Based Glucose Monitoring Market
2.8 Key Manufacturers Urine Based Glucose Monitoring Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Urine Based Glucose Monitoring Status and Outlook by Region
3.1 Global Urine Based Glucose Monitoring Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Urine Based Glucose Monitoring Historic Market Size by Region
3.2.1 Global Urine Based Glucose Monitoring Sales in Volume by Region (2018-2023)
3.2.2 Global Urine Based Glucose Monitoring Sales in Value by Region (2018-2023)
3.2.3 Global Urine Based Glucose Monitoring Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Urine Based Glucose Monitoring Forecasted Market Size by Region
3.3.1 Global Urine Based Glucose Monitoring Sales in Volume by Region (2024-2029)
3.3.2 Global Urine Based Glucose Monitoring Sales in Value by Region (2024-2029)
3.3.3 Global Urine Based Glucose Monitoring Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Urine Based Glucose Monitoring by Application
4.1 Urine Based Glucose Monitoring Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Urine Based Glucose Monitoring Market Size by Application
4.2.1 Global Urine Based Glucose Monitoring Market Size Overview by Application (2018-2029)
4.2.2 Global Urine Based Glucose Monitoring Historic Market Size Review by Application (2018-2023)
4.2.3 Global Urine Based Glucose Monitoring Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Urine Based Glucose Monitoring Sales Breakdown by Application (2018-2023)
4.3.2 Europe Urine Based Glucose Monitoring Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Urine Based Glucose Monitoring Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Urine Based Glucose Monitoring Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Urine Based Glucose Monitoring Sales Breakdown by Application (2018-2023)
5 North America Urine Based Glucose Monitoring by Country
5.1 North America Urine Based Glucose Monitoring Historic Market Size by Country
5.1.1 North America Urine Based Glucose Monitoring Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Urine Based Glucose Monitoring Sales in Volume by Country (2018-2023)
5.1.3 North America Urine Based Glucose Monitoring Sales in Value by Country (2018-2023)
5.2 North America Urine Based Glucose Monitoring Forecasted Market Size by Country
5.2.1 North America Urine Based Glucose Monitoring Sales in Volume by Country (2024-2029)
5.2.2 North America Urine Based Glucose Monitoring Sales in Value by Country (2024-2029)
6 Europe Urine Based Glucose Monitoring by Country
6.1 Europe Urine Based Glucose Monitoring Historic Market Size by Country
6.1.1 Europe Urine Based Glucose Monitoring Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Urine Based Glucose Monitoring Sales in Volume by Country (2018-2023)
6.1.3 Europe Urine Based Glucose Monitoring Sales in Value by Country (2018-2023)
6.2 Europe Urine Based Glucose Monitoring Forecasted Market Size by Country
6.2.1 Europe Urine Based Glucose Monitoring Sales in Volume by Country (2024-2029)
6.2.2 Europe Urine Based Glucose Monitoring Sales in Value by Country (2024-2029)
7 Asia-Pacific Urine Based Glucose Monitoring by Region
7.1 Asia-Pacific Urine Based Glucose Monitoring Historic Market Size by Region
7.1.1 Asia-Pacific Urine Based Glucose Monitoring Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Urine Based Glucose Monitoring Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Urine Based Glucose Monitoring Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Urine Based Glucose Monitoring Forecasted Market Size by Region
7.2.1 Asia-Pacific Urine Based Glucose Monitoring Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Urine Based Glucose Monitoring Sales in Value by Region (2024-2029)
8 Latin America Urine Based Glucose Monitoring by Country
8.1 Latin America Urine Based Glucose Monitoring Historic Market Size by Country
8.1.1 Latin America Urine Based Glucose Monitoring Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Urine Based Glucose Monitoring Sales in Volume by Country (2018-2023)
8.1.3 Latin America Urine Based Glucose Monitoring Sales in Value by Country (2018-2023)
8.2 Latin America Urine Based Glucose Monitoring Forecasted Market Size by Country
8.2.1 Latin America Urine Based Glucose Monitoring Sales in Volume by Country (2024-2029)
8.2.2 Latin America Urine Based Glucose Monitoring Sales in Value by Country (2024-2029)
9 Middle East and Africa Urine Based Glucose Monitoring by Country
9.1 Middle East and Africa Urine Based Glucose Monitoring Historic Market Size by Country
9.1.1 Middle East and Africa Urine Based Glucose Monitoring Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Urine Based Glucose Monitoring Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Urine Based Glucose Monitoring Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Urine Based Glucose Monitoring Forecasted Market Size by Country
9.2.1 Middle East and Africa Urine Based Glucose Monitoring Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Urine Based Glucose Monitoring Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott
10.1.1 Abbott Company Information
10.1.2 Abbott Introduction and Business Overview
10.1.3 Abbott Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Urine Based Glucose Monitoring Products Offered
10.1.5 Abbott Recent Development
10.2 Medtronic
10.2.1 Medtronic Company Information
10.2.2 Medtronic Introduction and Business Overview
10.2.3 Medtronic Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Medtronic Urine Based Glucose Monitoring Products Offered
10.2.5 Medtronic Recent Development
10.3 Roche
10.3.1 Roche Company Information
10.3.2 Roche Introduction and Business Overview
10.3.3 Roche Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Roche Urine Based Glucose Monitoring Products Offered
10.3.5 Roche Recent Development
10.4 Bayer AG
10.4.1 Bayer AG Company Information
10.4.2 Bayer AG Introduction and Business Overview
10.4.3 Bayer AG Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bayer AG Urine Based Glucose Monitoring Products Offered
10.4.5 Bayer AG Recent Development
10.5 B. Braun
10.5.1 B. Braun Company Information
10.5.2 B. Braun Introduction and Business Overview
10.5.3 B. Braun Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.5.4 B. Braun Urine Based Glucose Monitoring Products Offered
10.5.5 B. Braun Recent Development
10.6 Nipro Diagnostics
10.6.1 Nipro Diagnostics Company Information
10.6.2 Nipro Diagnostics Introduction and Business Overview
10.6.3 Nipro Diagnostics Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Nipro Diagnostics Urine Based Glucose Monitoring Products Offered
10.6.5 Nipro Diagnostics Recent Development
10.7 Life Scan Inc.(J&J)
10.7.1 Life Scan Inc.(J&J) Company Information
10.7.2 Life Scan Inc.(J&J) Introduction and Business Overview
10.7.3 Life Scan Inc.(J&J) Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Life Scan Inc.(J&J) Urine Based Glucose Monitoring Products Offered
10.7.5 Life Scan Inc.(J&J) Recent Development
10.8 Arkray Devices
10.8.1 Arkray Devices Company Information
10.8.2 Arkray Devices Introduction and Business Overview
10.8.3 Arkray Devices Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Arkray Devices Urine Based Glucose Monitoring Products Offered
10.8.5 Arkray Devices Recent Development
10.9 Nova Biomedical
10.9.1 Nova Biomedical Company Information
10.9.2 Nova Biomedical Introduction and Business Overview
10.9.3 Nova Biomedical Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Nova Biomedical Urine Based Glucose Monitoring Products Offered
10.9.5 Nova Biomedical Recent Development
10.10 Bionime Corporation
10.10.1 Bionime Corporation Company Information
10.10.2 Bionime Corporation Introduction and Business Overview
10.10.3 Bionime Corporation Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Bionime Corporation Urine Based Glucose Monitoring Products Offered
10.10.5 Bionime Corporation Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Urine Based Glucose Monitoring Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Urine Based Glucose Monitoring Industrial Chain Analysis
11.4 Urine Based Glucose Monitoring Market Dynamics
11.4.1 Urine Based Glucose Monitoring Industry Trends
11.4.2 Urine Based Glucose Monitoring Market Drivers
11.4.3 Urine Based Glucose Monitoring Market Challenges
11.4.4 Urine Based Glucose Monitoring Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Urine Based Glucose Monitoring Distributors
12.3 Urine Based Glucose Monitoring Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
